1. Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy. (3rd October 2022) Authors: Kadosaka, T; Watanabe, M; Natsui, H; Koizumi, T; Koya, T; Nakao, M; Hagiwara, H; Kamada, R; Temma, T; Anzai, T Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neuronal nitric oxide synthase inhibition exacerbates atrial electrical remodeling via small-conductance Ca2+-activated K+ channel activation. (19th May 2022) Authors: Koya, T; Watanabe, M; Natsui, H; Kadosaka, T; Koizumi, T; Nakao, M; Hagiwara, H; Kamada, R; Temma, T; Anazai, T Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗